Pro-resolution of inflammation: A potential strategy for treatment of acute lung injury/acute respiratory distress syndrome

Chinese Medical Journal

Volumn 127, Issue 5, 2014, Pages 801-802

  Shang, You ^a   Yao, Shang Long ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Resolution of inflammation

Indexed keywords

15 DEOXY DELTA12, 14 PROSTAGLANDIN J2; ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID DERIVATIVE; BML 111; CASPASE; DOCOSAHEXAENOIC ACID; ENZYME INHIBITOR; FATTY ACID; FORMYLPEPTIDE RECEPTOR; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLUCOCORTICOID RECEPTOR STIMULATING AGENT; HEME OXYGENASE 1; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOXIN A; LIPOXIN B; MISCELLANEOUS DRUGS AND AGENTS; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT; NORPHENAZONE; PAN CASPASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; REACTIVE OXYGEN METABOLITE; RESOLVIN; ROSIGLITAZONE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTIFICIAL VENTILATION; CONSERVATIVE TREATMENT; DOWN REGULATION; EDITORIAL; HUMAN; INFLAMMATION; LUNG EDEMA; NEUTROPHIL; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION; FLUID THERAPY; RESPIRATORY DISTRESS SYNDROME, ADULT;

ACUTE LUNG INJURY; FLUID THERAPY; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84896847284     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20133348     Document Type: Editorial

References (12)

1. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122: 2731-2740.
2. Serpa Neto A, Cardoso SO, Mantetta JA, Pereira VG, Esposito DC, Pasqualucci Mde O, et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 2012; 308: 1651-1659.
3. El Kebir D, Jozsef L, Pan W, Wang L, Petasis NA, Serhan CN, et al. 15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury. Am J Respir Crit Care Med 2009; 180: 311-319.
4. Gong J, Guo S, Li HB, Yuan SY, Shang Y, Yao SL, et al. BML-111, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats. Resuscitation 2012; 83: 907-912.
5. Li HB, Wang GZ, Gong J, Wu ZY, Guo S, Li B, et al. BML-111 attenuates hemorrhagic shock-induced acute lung injury through inhibiting activation of mitogen-activated protein kinase pathway in rats. J Surg Res 2013; 183: 710-719.
6. Li HB, Wu Z, Feng D, Gong J, Yao C, Wang Y, et al. BML-111, a lipoxin receptor agonist, attenuates ventilator-induced lung injury in rats. Shock 2013; Epub ahead of print.
7. Jin SW, Zhang L, Lian QQ, Liu D, Wu P, Yao SL, et al. Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1. Anesth Analg 2007; 104: 369-377.
8. Xie W, Wang H, Wang L, Yao C, Yuan R, Wu Q. Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. Lab Invest 2013; 93: 991-1000.
9. Wang L, Yuan RX, Yao CY, Wu QP, Christelle M, Xie WL, et al. Effects of resolvin D1 on inflammatory response and oxidative stress of LPS-induced acute lung injury in mice. Chin Med J 2014; 127: 803-809.
10. Li XW, Li CL, Liang WD, Bi YT, Chen MH, Dong S. Protectin D1 promotes resolution of inflammation in a murine model of lipopolysacchride-induced acute lung injury via enhancing neutrophil apoptosis. Chin Med J 2014; 127: 810-814.
11. Liu D, Geng ZL, Zhu WK, Wang HW, Chen Y, Liang J.15-deoxy-Δ12, 14-prostaglandin J2, an anti-inflammatory and pro-resolving lipid mediator, ameliorates endotoxin-induced acute lung injury in rats. Chin Med J 2014; 127: 815-820.
12. Wu ZY, Ming Y, Zhang Z, Wu J, Wu ZL, Yao SL. Edaravone rescues the lung by inhibiting lipid peroxidation and pro-inflammatory cytokines in a rat model. Chin Med J 2014; 127: 968-970.